Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiaojing Chi
Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain
Related publications
Fully Human Single-Domain Antibodies Against SARS-CoV-2
A Humanized Neutralizing Antibody Against MERS-CoV Targeting the Receptor-Binding Domain of the Spike Protein
Cell Research
Cell Biology
Molecular Biology
On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2
The 2019 Coronavirus (SARS-CoV-2) Surface Protein (Spike) S1 Receptor Binding Domain Undergoes Conformational Change Upon Heparin Binding.
Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights
Molecular Docking Study of Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein With Saikosaponin, a Triterpenoid Natural Product
Human Monoclonal Antibodies Block the Binding of SARS-CoV-2 Spike Protein to Angiotensin Converting Enzyme 2 Receptor
Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2
Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
Cell Reports
Biochemistry
Genetics
Molecular Biology